肝病患者的侵袭性真菌感染:重症监护单元的免疫学与临床考量
本文为综述,聚焦ICU内肝病患者侵袭性真菌感染(IFI)的免疫学与临床问题。肝衰竭导致复杂免疫功能障碍,使患者对感染易感;细菌感染常在入院时即存在且常为ICU入住主因,而IFI累及较小比例患者、多在ICU住院期间被发现。在ICU、尤其肝病患者中,IFI诊断常被延迟或忽视,尽管有有效且基本安全的抗真菌治疗,仍造成极高ICU死亡率。综述先概述正常抗真菌免疫及其在肝功能障碍时的受损,再讨论肝病中IFI,并分别审视念珠菌、曲霉和隐球菌三个最相关病原体,最后指出未来需关注的知识与实践差距。
要点
- 肝病患者因肝衰竭所致复杂免疫功能障碍,对感染存在独特易感性。
- 细菌感染常在入院时即存在,且常为ICU入住的主要原因;IFI累及较小比例患者,通常在ICU住院期间被发现。
- 在ICU、尤其肝病患者中,IFI诊断常被延迟或忽视。
- 尽管有有效且基本安全的抗真菌治疗,肝病患者IFI仍与极高ICU死亡率相关。
- 重症医生对肝病患者保持IFI警惕对改善结局至关重要。
适用人群与场景
- 重症监护单元(ICU)中的肝病患者。
红旗征与不能漏的情况
- 在ICU、尤其肝病患者中,IFI诊断常被延迟或忽视,尽管有有效且基本安全的抗真菌治疗,仍导致极高ICU死亡率。
研究设计与关键结果
- 综述指出,肝病患者入院时常见细菌感染且常为ICU入住主因;IFI累及较小比例患者,通常在ICU住院期间被发现。
- 综述分别审视了肝病中最相关的三个真菌病原体:念珠菌、曲霉和隐球菌。
- 综述结论强调未来需关注的知识与实践差距。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,为改善结局,重症监护临床医生对肝病患者的IFI保持警惕至关重要。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Patients with liver disease in the intensive care unit (ICU) face a unique susceptibility to infection due to the complex immune dysfunction resulting from hepatic failure. Bacterial infections are commonly present in these patients upon arrival to the hospital, often being the primary reason for ICU admission. In contrast, invasive fungal infections (IFIs) afflict a smaller percentage of patients and are usually discovered in the course of the ICU stay. IFI diagnosis in the ICU, particularly in patients with liver disease, is often delayed or overlooked, contributing to the extremely high ICU mortality associated with IFI in these patients despite the availability of effective (and largely safe) antifungal therapy. Thus, to improve outcomes, it is crucial for intensive care clinicians to be vigilant for IFIs in patients with liver disease. This review aims to contribute to the intensive care literature in this regard. We begin with an overview of normal antifungal immunity followed by a summary of how it may become compromised in the setting of hepatic dysfunction. Next, a general discussion of IFIs in liver disease is presented and then the three most relevant fungal pathogens, namely Candida, Aspergillus, and Cryptococcus, are individually examined. This review concludes by highlighting key knowledge and practice gaps that require attention by the scientific and clinical communities in the coming years.
参考来源
- Epelbaum O, de Moraes AG, Olson JC, et al. Invasive fungal infections in patients with liver disease: immunological and clinical considerations for the intensive care unit. Intensive Care Med. 2025. PMID: 39961846. doi:10.1007/s00134-025-07797-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。